Replies to post #29145 on Intellipharmaceutics International Inc. (IPCI)

[fabius]

Wimus,
I tend to agree that expectations about an approval (tentative) should be very low.

That's way I am screaming at the company to do something (strategic) BEFORE the PDUFA date. My biggest fear is that Odidi will be 100% on the Rexista required studies, instead of moving in parallel with other strategic options, come of which we know being MUCH bigger than Rexista.

if this happens, when FDA doesn't approve we are going to be crashed by another 50% free fall. it really seems to me Odidi took the wrong path when he decided to be a listed companies.
I sound pessimistic, but I am still holding long here, hoping for a new fresh change in the company strategic directions.

[wimike]

wimusky.........agree 100% I would go as far as saying 99-1 odds as a poker player. THe extra revenue we will be getting will not cover all the expenses we are now incurring. That is just my opinion. We can not battle all these lawsuits and R&D and NOT have more money. We need desperately a partner with some upfront money or we need to be bought out. If they decide to dilute they wil wish they never did as this will be in the pink sheets.
Yes all the above is my opinion but it is getting to be a sobering reality. I m sick the way the company has been run. The CEO could hardly finish a sentence at the AdCom and had to be rescued. Now if we hire a top fun CEO we again do not have money for that. So where do we go from here?
He should take a buy out for $3/share in a NY minute.